ASP1570, ASP1570, KEYTRUDA 25 mg/mL concentrate for solution for infusion
1570-CL-0101
Phase 2 small_molecule active
Quick answer
ASP1570, ASP1570, KEYTRUDA 25 mg/mL concentrate for solution for infusion for Advanced Solid Tumors is a Phase 2 program (small_molecule) at Astellas Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Astellas Pharma GmbH
- Indication
- Advanced Solid Tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active